1. Home
  2. COSM vs GDTC Comparison

COSM vs GDTC Comparison

Compare COSM & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cosmos Health Inc.

COSM

Cosmos Health Inc.

HOLD

Current Price

$0.29

Market Cap

12.9M

Sector

Health Care

ML Signal

HOLD

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

HOLD

Current Price

$1.02

Market Cap

12.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COSM
GDTC
Founded
2009
2018
Country
United States
Singapore
Employees
N/A
N/A
Industry
Other Pharmaceuticals
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.9M
12.4M
IPO Year
2009
2021

Fundamental Metrics

Financial Performance
Metric
COSM
GDTC
Price
$0.29
$1.02
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.1M
12.0K
Earning Date
04-15-2026
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
46.15
N/A
EPS
N/A
N/A
Revenue
$65,271,815.00
N/A
Revenue This Year
$54.08
N/A
Revenue Next Year
$32.66
N/A
P/E Ratio
N/A
N/A
Revenue Growth
19.93
N/A
52 Week Low
$0.16
$0.68
52 Week High
$1.32
$3.68

Technical Indicators

Market Signals
Indicator
COSM
GDTC
Relative Strength Index (RSI) 58.55 45.65
Support Level $0.28 $0.93
Resistance Level $0.41 $1.09
Average True Range (ATR) 0.04 0.07
MACD 0.01 0.00
Stochastic Oscillator 65.76 32.47

Price Performance

Historical Comparison
COSM
GDTC

About COSM Cosmos Health Inc.

Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: